Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases.

IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Havva Sezer, Hande Bulut Canbaz, Serdar Tezalman, Tarık Terzioğlu, Eda Nur Çilingiroğlu, Bülent Çolakoğlu, Dilek Yazıcı, Oğuzhan Deyneli, Mehmet Onur Demirkol, Adnan Batman, Seçil Özışık, Yersu Yapran, Faruk Alagöl
{"title":"Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases.","authors":"Havva Sezer,&nbsp;Hande Bulut Canbaz,&nbsp;Serdar Tezalman,&nbsp;Tarık Terzioğlu,&nbsp;Eda Nur Çilingiroğlu,&nbsp;Bülent Çolakoğlu,&nbsp;Dilek Yazıcı,&nbsp;Oğuzhan Deyneli,&nbsp;Mehmet Onur Demirkol,&nbsp;Adnan Batman,&nbsp;Seçil Özışık,&nbsp;Yersu Yapran,&nbsp;Faruk Alagöl","doi":"10.5603/EP.a2023.0055","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Our aims were to explore the relationship between primary hyperparathyroidism (pHPT) and malignant tumour development, to determine the frequency and the time of occurrence of malignant tumours in patients with pHPT, and to evaluate the characteristics of pHPT in these patients.</p><p><strong>Material and methods: </strong>This retrospective cohort study included consecutive individuals who were diagnosed with pHPT aged 18 years or older in a university hospital during a 7-year period. A total of 198 patients with pHPT were reviewed retrospectively. Demographic, clinical, biochemical, radiologic findings, and histopathological diagnosis were collected from the electronic medical records of the hospital system.</p><p><strong>Results: </strong>The mean age of the study population was 58 ± 13 years and was predominantly female (female/male: 162/36). There were 42 (21.2%) patients with malignant tumours. Five (12%) out of 42 patients had metachronous double malignancies. The most common 2 concurrent malignancies were breast (36.1%) and thyroid (17.0%). Sixty-eight per cent of the malignant tumours occurred before the diagnosis of pHPT. A higher percentage (87.5%) of simultaneous tumours was seen in the thyroid gland. No statistically significant differences were observed between patients with and without malignant tumours in terms of demographic, clinical, biochemical, radiological, and histopathological features. The median follow-up duration was 24 months after parathyroid surgery.</p><p><strong>Conclusion: </strong>The results of this study revealed that pHPT was associated with various tumour types. The frequency of malignant tumours was 21.2%. Breast and thyroid cancers were the most common 2 cancers coexisting with pHPT. A large percentage of malignant tumours occurred before the diagnosis of pHPT. A higher percentage of simultaneous tumours was seen in the thyroid gland. pHPT patients with and without malignant tumours seemed to have similar characteristics.</p>","PeriodicalId":11551,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2023-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/EP.a2023.0055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Our aims were to explore the relationship between primary hyperparathyroidism (pHPT) and malignant tumour development, to determine the frequency and the time of occurrence of malignant tumours in patients with pHPT, and to evaluate the characteristics of pHPT in these patients.

Material and methods: This retrospective cohort study included consecutive individuals who were diagnosed with pHPT aged 18 years or older in a university hospital during a 7-year period. A total of 198 patients with pHPT were reviewed retrospectively. Demographic, clinical, biochemical, radiologic findings, and histopathological diagnosis were collected from the electronic medical records of the hospital system.

Results: The mean age of the study population was 58 ± 13 years and was predominantly female (female/male: 162/36). There were 42 (21.2%) patients with malignant tumours. Five (12%) out of 42 patients had metachronous double malignancies. The most common 2 concurrent malignancies were breast (36.1%) and thyroid (17.0%). Sixty-eight per cent of the malignant tumours occurred before the diagnosis of pHPT. A higher percentage (87.5%) of simultaneous tumours was seen in the thyroid gland. No statistically significant differences were observed between patients with and without malignant tumours in terms of demographic, clinical, biochemical, radiological, and histopathological features. The median follow-up duration was 24 months after parathyroid surgery.

Conclusion: The results of this study revealed that pHPT was associated with various tumour types. The frequency of malignant tumours was 21.2%. Breast and thyroid cancers were the most common 2 cancers coexisting with pHPT. A large percentage of malignant tumours occurred before the diagnosis of pHPT. A higher percentage of simultaneous tumours was seen in the thyroid gland. pHPT patients with and without malignant tumours seemed to have similar characteristics.

原发性甲状旁腺功能亢进症患者先前,同时或随后发生恶性肿瘤:更仔细地观察单三级中心病例。
前言:我们的目的是探讨原发性甲状旁腺功能亢进(pHPT)与恶性肿瘤发展的关系,确定pHPT患者恶性肿瘤发生的频率和时间,并评价这些患者的pHPT特征。材料和方法:本回顾性队列研究纳入了在大学医院连续7年被诊断为pHPT的18岁或以上的个体。对198例pHPT患者进行回顾性分析。从医院系统的电子病历中收集人口统计学、临床、生化、放射学检查结果和组织病理学诊断。结果:研究人群的平均年龄为58±13岁,以女性为主(女性/男性:162/36)。恶性肿瘤42例(21.2%)。42例患者中有5例(12%)有异时性双重恶性肿瘤。最常见的2种并发恶性肿瘤是乳腺(36.1%)和甲状腺(17.0%)。68%的恶性肿瘤发生在pHPT诊断之前。甲状腺同时出现肿瘤的比例较高(87.5%)。恶性肿瘤患者与非恶性肿瘤患者在人口学、临床、生化、放射学和组织病理学特征方面无统计学差异。甲状旁腺手术后的中位随访时间为24个月。结论:本研究结果显示pHPT与多种肿瘤类型有关。恶性肿瘤发生率为21.2%。乳腺癌和甲状腺癌是最常见的与pHPT共存的癌症。很大比例的恶性肿瘤发生在pHPT的诊断之前。甲状腺同时出现肿瘤的比例较高。有和没有恶性肿瘤的pHPT患者似乎具有相似的特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endokrynologia Polska
Endokrynologia Polska ENDOCRINOLOGY & METABOLISM-
CiteScore
2.60
自引率
9.50%
发文量
129
审稿时长
6-12 weeks
期刊介绍: "Endokrynologia Polska" publishes papers in English on all aspects of clinical and experimental endocrinology. The following types of papers may be submitted for publication: original articles, reviews, case reports, postgraduate education, letters to the Editor (Readers’ Forum) and announcements of scientific meetings, conferences and congresses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信